• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Genetic diversity within Mycobacterium tuberculosis complex impacts on the accuracy of genotypic pyrazinamide drug-susceptibility assay.

作者信息

Köser Claudio U, Comas Iñaki, Feuerriegel Silke, Niemann Stefan, Gagneux Sebastien, Peacock Sharon J

机构信息

Department of Medicine, University of Cambridge, Cambridge, United Kingdom.

Genomics and Health Unit, FISABIO, Valencia, Spain; CIBER (Centros de Investigación Biomédica en Red) in Epidemiology and Public Health, Spain.

出版信息

Tuberculosis (Edinb). 2014 Jul;94(4):451-3. doi: 10.1016/j.tube.2014.04.002. Epub 2014 Apr 24.

DOI:10.1016/j.tube.2014.04.002
PMID:24870943
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4075347/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa22/4075347/1b0c27241f4d/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa22/4075347/1b0c27241f4d/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa22/4075347/1b0c27241f4d/gr1.jpg

相似文献

1
Genetic diversity within Mycobacterium tuberculosis complex impacts on the accuracy of genotypic pyrazinamide drug-susceptibility assay.结核分枝杆菌复合群内的遗传多样性对基因型吡嗪酰胺药敏试验的准确性有影响。
Tuberculosis (Edinb). 2014 Jul;94(4):451-3. doi: 10.1016/j.tube.2014.04.002. Epub 2014 Apr 24.
2
Pyrazinamide Resistance among Multidrug-Resistant Mycobacterium tuberculosis Clinical Isolates in Myanmar.缅甸耐多药结核分枝杆菌临床分离株中的吡嗪酰胺耐药性
Antimicrob Agents Chemother. 2018 Feb 23;62(3). doi: 10.1128/AAC.01984-17. Print 2018 Mar.
3
Pyrazinamide resistance among drug-resistant Mycobacterium tuberculosis isolates at a referral hospital.一家转诊医院耐药结核分枝杆菌分离株中的吡嗪酰胺耐药情况。
Diagn Microbiol Infect Dis. 2013 Dec;77(4):380-1. doi: 10.1016/j.diagmicrobio.2013.08.014. Epub 2013 Sep 26.
4
How To Optimally Combine Genotypic and Phenotypic Drug Susceptibility Testing Methods for Pyrazinamide.如何优化吡嗪酰胺基因型和表型药敏试验方法的联合应用
Antimicrob Agents Chemother. 2020 Aug 20;64(9). doi: 10.1128/AAC.01003-20.
5
Phenotypic and genotypic characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis clinical isolates in Hangzhou, China.中国杭州耐多药结核分枝杆菌临床分离株中吡嗪酰胺耐药的表型和基因型特征。
Clin Microbiol Infect. 2018 Sep;24(9):1016.e1-1016.e5. doi: 10.1016/j.cmi.2017.12.012. Epub 2017 Dec 26.
6
Characterization of pyrazinamide resistance in consecutive multidrug-resistant isolates in sweden between 2003 and 2015.2003年至2015年瑞典连续多药耐药分离株中吡嗪酰胺耐药性的特征分析
Int J Mycobacteriol. 2017 Apr-Jun;6(2):156-161. doi: 10.4103/ijmy.ijmy_23_17.
7
Association between pncA gene mutations, pyrazinamidase activity, and pyrazinamide susceptibility testing in Mycobacterium tuberculosis.结核分枝杆菌中pncA基因突变、吡嗪酰胺酶活性与吡嗪酰胺药敏试验之间的关联
Antimicrob Agents Chemother. 2014 Aug;58(8):4928-30. doi: 10.1128/AAC.02394-14. Epub 2014 May 27.
8
Pyrazinamide resistance in multidrug-resistant Mycobacterium tuberculosis isolates in Japan.日本耐多药结核分枝杆菌分离株中的吡嗪酰胺耐药性。
Clin Microbiol Infect. 2010 Aug;16(8):1164-8. doi: 10.1111/j.1469-0691.2009.03078.x. Epub 2009 Oct 14.
9
Rapid microarray-based assay for detection of pyrazinamide resistant Mycobacterium tuberculosis.基于快速微阵列的结核分枝杆菌吡嗪酰胺耐药检测方法。
Diagn Microbiol Infect Dis. 2019 Jun;94(2):147-154. doi: 10.1016/j.diagmicrobio.2018.12.011. Epub 2018 Dec 30.
10
Next-generation sequencing for identifying pyrazinamide resistance in Mycobacterium tuberculosis.用于鉴定结核分枝杆菌中吡嗪酰胺耐药性的新一代测序技术。
Clin Infect Dis. 2014 Mar;58(6):903-4. doi: 10.1093/cid/cit811. Epub 2013 Dec 12.

引用本文的文献

1
Mutations Associated with Pyrazinamide Resistance in Mycobacterium tuberculosis: A Review and Update.结核分枝杆菌吡嗪酰胺耐药相关突变：综述与更新。
Curr Microbiol. 2022 Oct 8;79(11):348. doi: 10.1007/s00284-022-03032-y.
2
Analysis of mutations in pncA reveals non-overlapping patterns among various lineages of Mycobacterium tuberculosis.pncA 突变分析揭示了结核分枝杆菌各谱系之间非重叠的模式。
Sci Rep. 2018 Mar 15;8(1):4628. doi: 10.1038/s41598-018-22883-9.
3
OMNIgene.SPUTUM suppresses contaminants while maintaining viability and obviates cold-chain transport.

本文引用的文献

1
Phylogenetic polymorphisms in antibiotic resistance genes of the Mycobacterium tuberculosis complex.结核分枝杆菌复合群抗生素耐药基因的系统发育多态性。
J Antimicrob Chemother. 2014 May;69(5):1205-10. doi: 10.1093/jac/dkt535. Epub 2014 Jan 23.
2
Pyrazinamide susceptibility testing of Mycobacterium tuberculosis by high resolution melt analysis.结核分枝杆菌高分辨率熔解曲线分析药敏检测法。
Tuberculosis (Edinb). 2014 Jan;94(1):20-5. doi: 10.1016/j.tube.2013.10.006. Epub 2013 Nov 1.
3
Out-of-Africa migration and Neolithic coexpansion of Mycobacterium tuberculosis with modern humans.
OMNIgene·痰液检测试剂盒可抑制污染物，同时保持样本活性，无需冷链运输。
ERJ Open Res. 2018 Feb 16;4(1). doi: 10.1183/23120541.00074-2017. eCollection 2018 Jan.
4
Genetic determinants involved in p-aminosalicylic acid resistance in clinical isolates from tuberculosis patients in northern China from 2006 to 2012.2006年至2012年中国北方肺结核患者临床分离株中对对氨基水杨酸耐药性的遗传决定因素。
Antimicrob Agents Chemother. 2015 Feb;59(2):1320-4. doi: 10.1128/AAC.03695-14. Epub 2014 Nov 24.
5
Mycobacterium tuberculosis pyrazinamide resistance determinants: a multicenter study.结核分枝杆菌吡嗪酰胺耐药决定因素：一项多中心研究。
mBio. 2014 Oct 21;5(5):e01819-14. doi: 10.1128/mBio.01819-14.
6
Whole-genome sequencing to control antimicrobial resistance.全基因组测序以控制抗菌药物耐药性。
Trends Genet. 2014 Sep;30(9):401-7. doi: 10.1016/j.tig.2014.07.003. Epub 2014 Aug 3.
非洲以外的迁徙和新石器时代结核分枝杆菌与现代人的共同扩张。
Nat Genet. 2013 Oct;45(10):1176-82. doi: 10.1038/ng.2744. Epub 2013 Sep 1.
4
Whole-genome sequencing for rapid susceptibility testing of M. tuberculosis.用于结核分枝杆菌快速药敏试验的全基因组测序
N Engl J Med. 2013 Jul 18;369(3):290-2. doi: 10.1056/NEJMc1215305.
5
Consequences of whiB7 (Rv3197A) mutations in Beijing genotype isolates of the Mycobacterium tuberculosis complex.结核分枝杆菌复合群北京基因型菌株中whiB7（Rv3197A）突变的后果
Antimicrob Agents Chemother. 2013 Jul;57(7):3461. doi: 10.1128/AAC.00626-13.
6
Mycobacterial lineages causing pulmonary and extrapulmonary tuberculosis, Ethiopia.导致肺和肺外结核的分枝杆菌谱系，埃塞俄比亚。
Emerg Infect Dis. 2013 Mar;19(3):460-3. doi: 10.3201/eid1903.120256.
7
Mycobacterium canettii is intrinsically resistant to both pyrazinamide and pyrazinoic acid.卡内蒂分枝杆菌对吡嗪酰胺和吡嗪酸均具有内在抗性。
J Antimicrob Chemother. 2013 Jun;68(6):1439-40. doi: 10.1093/jac/dkt042. Epub 2013 Feb 26.
8
Importance of the genetic diversity within the Mycobacterium tuberculosis complex for the development of novel antibiotics and diagnostic tests of drug resistance.结核分枝杆菌复合群内遗传多样性对新型抗生素的开发和耐药性诊断检测的重要性。
Antimicrob Agents Chemother. 2012 Dec;56(12):6080-7. doi: 10.1128/AAC.01641-12. Epub 2012 Sep 24.
9
Gene sequencing for routine verification of pyrazinamide resistance in Mycobacterium tuberculosis: a role for pncA but not rpsA.结核分枝杆菌吡嗪酰胺耐药常规验证的基因测序：pncA 而非 rpsA 的作用。
J Clin Microbiol. 2012 Nov;50(11):3726-8. doi: 10.1128/JCM.00620-12. Epub 2012 Aug 15.
10
Systematic analysis of pyrazinamide-resistant spontaneous mutants and clinical isolates of Mycobacterium tuberculosis.结核分枝杆菌吡嗪酰胺耐药自发突变株和临床分离株的系统分析。
Antimicrob Agents Chemother. 2012 Oct;56(10):5186-93. doi: 10.1128/AAC.05385-11. Epub 2012 Jul 23.